Raymond James adds UnitedHealth, drops GoodRx from favorites list
| DWOIX Fund | USD 20.63 0.30 1.43% |
Slightly above 61% of Dreyfus Research's investor base is looking to short. The analysis of overall sentiment of trading Dreyfus Research Growth mutual fund suggests that many investors are alarmed at this time. Dreyfus Research's investing sentiment can be driven by a variety of factors including economic data, Dreyfus Research's earnings reports, geopolitical events, and overall market trends.
Dreyfus |
Raymond James has added UnitedHealth Group to its favorites list, citing the stocks recent underperformance versus the SP 500, but deleted GoodRx . Read more here.
Read at seekingalpha.com
 |
Dreyfus Research Fundamental Analysis
We analyze Dreyfus Research's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dreyfus Research using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dreyfus Research based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Dreyfus Research is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Dreyfus Research Growth Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dreyfus Research mutual fund to make a market-neutral strategy. Peer analysis of Dreyfus Research could also be used in its relative valuation, which is a method of valuing Dreyfus Research by comparing valuation metrics with similar companies.
Peers
Dreyfus Research Related Equities
| DIEYX | Dreyfus International | 0.87 | ||||
| DIERX | Dreyfus International | 0.87 | ||||
| DINIX | Dreyfus International | 0.76 | ||||
| DISYX | International Stock | 0.58 | ||||
| DISRX | International Stock | 0.57 | ||||
| DIMIX | Dreyfus Short | 0.08 | ||||
| DHYYX | Dreyfus High | 0.00 | ||||
| DIBYX | Dreyfus International | 0.08 | ||||
| DIBRX | Dreyfus International | 0.24 | ||||
| SSETX | Dreyfusthe Boston | 1.31 |
Other Information on Investing in Dreyfus Mutual Fund
Dreyfus Research financial ratios help investors to determine whether Dreyfus Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dreyfus with respect to the benefits of owning Dreyfus Research security.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |